Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Contraception and Contraceptive Drugs

  Free Subscription

Articles published in Contraception

Retrieve available abstracts of 325 articles:
HTML format

Single Articles

    June 2023
  1. OSTERBUR BADHEY ML, Li S, Alimena S, Johnson NR, et al
    Allergic and infectious complications of Etonogestrel implant placements: A case series.
    Contraception. 2023;122:109994.
    PubMed     Abstract available

  2. ANJOS FCQS, Marcelino AC, Espejo-Arce X, Pereira PDC, et al
    Pain and ease of insertion of three different intrauterine devices in Brazilian adolescents: A participant-blinded randomized trial.
    Contraception. 2023;122:109997.
    PubMed     Abstract available

  3. WOLLUM A, Zuniga C, Blanchard K, Teal S, et al
    A commentary on progestin-only pills and the "three-hour window" guidelines: Timing of ingestion and mechanisms of action.
    Contraception. 2023;122:109978.
    PubMed     Abstract available

  4. CIRRINCIONE LR, Nakalema S, Chappell CA, Byakika-Kibwika P, et al
    Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
    Contraception. 2023;122:109975.
    PubMed     Abstract available

    May 2023
  5. MANG A, Jetelina KK, Mcneely C, Durante JC, et al
    Characteristics of parents who think intrauterine devices or contraceptive implants are "best" for their daughter: An exploratory analysis.
    Contraception. 2023 May 30:110084. doi: 10.1016/j.contraception.2023.110084.
    PubMed     Abstract available

  6. LOH M, Niu L, Arden M, Burk RD, et al
    Long-acting reversible contraception and condom use: A cohort study of female adolescents and young adults in New York City.
    Contraception. 2023 May 30:110081. doi: 10.1016/j.contraception.2023.110081.
    PubMed     Abstract available

  7. SULGER E, Jung C, Nippita S
    Avoiding unintended pregnancy during transition from copper intrauterine device to etonogestrel contraceptive implant: A case report.
    Contraception. 2023 May 29:110085. doi: 10.1016/j.contraception.2023.110085.
    PubMed     Abstract available

  8. SONALKAR S, Kete C, McAllister A, Afreen R, et al
    Perceptions of HIV risk screening strategies among patients seeking abortion, contraception, and pregnancy loss management in the United States.
    Contraception. 2023 May 18:110063. doi: 10.1016/j.contraception.2023.110063.
    PubMed     Abstract available

  9. AMORY JK, Blithe DL, Ware RS, Swerdloff RS, et al
    Design of an International Male Contraceptive Efficacy Trial Using a Self-Administered Daily Transdermal Gel Containing Testosterone and Segesterone Acetate (Nestorone(R)).
    Contraception. 2023 May 18:110064. doi: 10.1016/j.contraception.2023.110064.
    PubMed     Abstract available

  10. SHAW JG, Goldthwaite LM, Maric I, Shaw KA, et al
    Postpartum long-acting reversible contraception among privately insured: national analysis 2007-2016, by term and preterm birth.
    Contraception. 2023 May 18:110065. doi: 10.1016/j.contraception.2023.110065.
    PubMed     Abstract available

  11. FOSTER AM, Darney BG, Nguyen BT, Russo J, et al
    Advancing diversity, equity, inclusion, and anti-racism in Contraception: A statement of commitment from the Editorial Board.
    Contraception. 2023 May 17:110066. doi: 10.1016/j.contraception.2023.110066.

  12. ERMIAS Y, Averbach SH, Dey AK, Gebrehanna E, et al
    The Association Between Quality of Contraceptive Counseling and Selection of Contraceptive Method Post-counseling Among Women in Ethiopia.
    Contraception. 2023 May 11:110060. doi: 10.1016/j.contraception.2023.110060.
    PubMed     Abstract available

  13. RAYMOND EG, Mark A, Grossman D, Beasley A, et al
    Medication abortion with misoprostol-only: A sample protocol.
    Contraception. 2023;121:109998.

  14. KOENIG LR, Raymond EG, Gold M, Boraas CM, et al
    Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
    Contraception. 2023;121:109962.
    PubMed     Abstract available

    April 2023
  15. RODRIGUEZ MI, Skye M, Schrote K, Linz R, et al
    Contraceptive services in Oregon's state-funded network during the COVID-19 pandemic.
    Contraception. 2023 Apr 21:110054. doi: 10.1016/j.contraception.2023.110054.
    PubMed     Abstract available

  16. JONES EJ, Dehlendorf C, Kriz R, Grzeniewski M, et al
    Using the Person-Centered Contraceptive Counseling (PCCC) Measure for Quality Improvement.
    Contraception. 2023 Apr 12:110040. doi: 10.1016/j.contraception.2023.110040.
    PubMed     Abstract available

  17. SHEA M, Decker E, LeRoy L, Winter M, et al
    Testing the Validity and Reliability of the Person-Centered Contraceptive Care (PCCC) Performance Measure in a Real-World Contraceptive Access Program.
    Contraception. 2023 Apr 6:110039. doi: 10.1016/j.contraception.2023.110039.
    PubMed     Abstract available

  18. PAI M, Rigler N, de Oliveira BR, Mody SK, et al
    "My implant is expiring": A national U.S. mystery shopper study regarding extended use of the contraceptive implant.
    Contraception. 2023 Apr 3:110038. doi: 10.1016/j.contraception.2023.110038.
    PubMed     Abstract available

  19. SHADY NW, Farouk HA, Sallam HF
    A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in persons delivered only by cesarean delivery. Contraceptio
    Contraception. 2023;120:109973.

  20. QUINN DA, Sileanu FE, Borrero S, Callegari LS, et al
    Reproductive health services: A missed opportunity in VA primary care?
    Contraception. 2023;120:109957.
    PubMed     Abstract available

  21. GILBERT AL, Gelfand D, Fortin J, Roncari D, et al
    At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location.
    Contraception. 2023;120:109955.
    PubMed     Abstract available

  22. JENSEN JT, Reinecke I, Post TM, Lukkari-Lax E, et al
    Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs.
    Contraception. 2023;120:109954.
    PubMed     Abstract available

  23. REED S, Minh TD, Lange JA, Koro C, et al
    Pregnancy and pregnancy outcomes in a prospective cohort study: Final results from the Nexplanon Observational Risk Assessment Study (NORA).
    Contraception. 2023;120:109920.
    PubMed     Abstract available

  24. SHOCHET T, Turok D, Frye LJ, Sexsmith CD, et al
    Single dose letrozole and misoprostol for termination of pregnancy through 63 days' gestation: A pilot study.
    Contraception. 2023;120:109924.
    PubMed     Abstract available

    March 2023
  25. LAZORWITZ A, Sheeder J, Teal S
    The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: a pharmacokinetic and pharmacodynamic study.
    Contraception. 2023 Mar 28:110035. doi: 10.1016/j.contraception.2023.110035.
    PubMed     Abstract available

  26. DEHLENDORF C, Vittinghoff E, Silverstein I, Fox E, et al
    Prioritizing Patient Experience: Validation of the Person-Centered Contraceptive Counseling Measure as a Performance Measure.
    Contraception. 2023 Mar 17:110010. doi: 10.1016/j.contraception.2023.110010.
    PubMed     Abstract available

  27. STUART GS, Yates L, Crump J, Allison BA, et al
    Single-visit insertion of long-acting reversible contraception in a single health system.
    Contraception. 2023 Mar 15:110009. doi: 10.1016/j.contraception.2023.110009.
    PubMed     Abstract available

  28. NGUYEN BT, Jacobsohn TL
    Men's willingness to use novel male contraception is linked to gender-equitable attitudes: results from an exploratory online survey.
    Contraception. 2023 Mar 14:110001. doi: 10.1016/j.contraception.2023.110001.
    PubMed     Abstract available

  29. WILKINSON TA, Meredith AH, Katz AJ, Meagher CG, et al
    Assessment of Adolescent Decision-Making Capacity for Pharmacy Access to Hormonal Contraception.
    Contraception. 2023 Mar 11:110002. doi: 10.1016/j.contraception.2023.110002.
    PubMed     Abstract available

  30. MERZ AA, Kerns JL, Logan R, Gutierrez S, et al
    Contraceptive care in the United States during the COVID-19 pandemic: a social media survey study of contraceptive access, telehealth use and telehealth quality.
    Contraception. 2023 Mar 3:110000. doi: 10.1016/j.contraception.2023.110000.
    PubMed     Abstract available

  31. ZUNIGA C, Blanchard K, Harper CC, Wollum A, et al
    Effectiveness and efficacy rates of progestin-only pills: A comprehensive literature review.
    Contraception. 2023;119:109925.
    PubMed     Abstract available

  32. BAUM SE, Sierra G, Grossman D, Vizcarra E, et al
    Comparing preference for and use of medication abortion in Texas after policy changes in 2014 and 2018.
    Contraception. 2023;119:109912.
    PubMed     Abstract available

  33. BAYARD KE, Fabricant SP, White JD, Gordon B, et al
    Infectious outcomes following immediate postplacental intrauterine device placement in the setting of chorioamnionitis: An exploratory, retrospective study.
    Contraception. 2023;119:109913.
    PubMed     Abstract available

  34. ARENA A, Moro E, Degli Esposti E, Zanello M, et al
    How much will it hurt? Factors associated with pain experience in women undergoing medication abortion during the first trimester.
    Contraception. 2023;119:109916.
    PubMed     Abstract available

  35. HAMRICK JE, Ahmed AE, Witkop CT, Manetz KE, et al
    Unintended pregnancy among U.S. military active duty servicemembers: Estimates for 2018 and trends since 2005.
    Contraception. 2023;119:109894.
    PubMed     Abstract available

    February 2023
  36. BURY F, Iguyovwe V, Trivett M, Baraitser P, et al
    Patterns of use of emergency and oral contraceptives from an online service in the UK during the COVID-19 pandemic: a quantitative study of routinely collected data.
    Contraception. 2023 Feb 25:109992. doi: 10.1016/j.contraception.2023.109992.
    PubMed     Abstract available

  37. THORNTON M, Arora KS
    Reproductive Justice in Post-Roe America: Impact of Restricted Abortion Access on Patients Seeking Permanent Contraception.
    Contraception. 2023 Feb 24:109995. doi: 10.1016/j.contraception.2023.109995.
    PubMed     Abstract available

  38. EDMONDSON S, Conrado AB, Loria H, McLeigh J, et al
    Caregivers of youth in foster care in Texas and their role in contraception decision-making for adolescents in care.
    Contraception. 2023 Feb 23:109993. doi: 10.1016/j.contraception.2023.109993.
    PubMed     Abstract available

  39. THOMPSON EL, Galvin AM, Ashvita Garg M, Diener A, et al
    A Socioecological Perspective to Contraceptive Access for Women Experiencing Homelessness in the United States.
    Contraception. 2023 Feb 23:109991. doi: 10.1016/j.contraception.2023.109991.
    PubMed     Abstract available

  40. CONGY J, Bouyer J, de La Rochebrochard E
    Low-income women and use of prescribed contraceptives in a context of full health insurance coverage in France, 2019.
    Contraception. 2023 Feb 7:109976. doi: 10.1016/j.contraception.2023.109976.
    PubMed     Abstract available

  41. BIGGS MA, Serrano S, Valladares ES, Grossman D, et al
    Development of a Spanish-language drug facts label prototype for a combination mifepristone and misoprostol medication abortion product.
    Contraception. 2023;118:109906.
    PubMed     Abstract available

  42. FAY KE, Traore F, Amico JR
    Intrauterine device self-removal practices during the COVID-19 pandemic among family planning clinics.
    Contraception. 2023;118:109889.
    PubMed     Abstract available

  43. MINNS A, Dehlendorf C, Peahl AF, Heisler M, et al
    Elevating the Patient Voice in Contraceptive Care Quality Improvement: A Qualitative Study of Patient Preferences for Peripastum Contraceptive Care.
    Contraception. 2023 Feb 1:109960. doi: 10.1016/j.contraception.2023.109960.
    PubMed     Abstract available

    January 2023
  44. AGARWAL K, Dewan R
    Evaluation of acceptability, safety and continuation rates of centchroman as post-abortion nonsteroidal contraceptive pill.
    Contraception. 2023 Jan 31:109961. doi: 10.1016/j.contraception.2023.109961.
    PubMed     Abstract available

  45. RODRIGUEZ MI, Daly A, Meath T, Watson K, et al
    Catholic sole community hospital s are associated with decreased receipt of postpartum permanent contraception among Medicaid recipients.
    Contraception. 2023 Jan 25:109959. doi: 10.1016/j.contraception.2023.109959.
    PubMed     Abstract available

  46. SALCEDO J, Cleland K, Bartz D, Thompson I, et al
    Society of Family Planning Clinical Recommendations: Emergency contraception.
    Contraception. 2023 Jan 21:109958. doi: 10.1016/j.contraception.2023.109958.
    PubMed     Abstract available

  47. MOSLEY EA, Monaco A, Zite N, Rosenfeld E, et al
    U.S. physicians' perspectives on the complexities and challenges of permanent contraception provision.
    Contraception. 2023 Jan 11:109948. doi: 10.1016/j.contraception.2023.109948.
    PubMed     Abstract available

  48. KEY K, Wollum A, Asetoyer C, Cervantes M, et al
    Challenges accessing contraceptive care and interest in over-the-counter oral contraceptive pill use among Black, Indigenous, and people of color: an online cross-sectional survey.
    Contraception. 2023 Jan 11:109950. doi: 10.1016/j.contraception.2023.109950.
    PubMed     Abstract available

  49. SARAYANI A, Winterstein A, Cristofoletti R, Vozmediano V, et al
    Real-World Effect of a Potential Drug-Drug Interaction Between Topiramate and Oral Contraceptives on Unintended Pregnancy Outcomes.
    Contraception. 2023 Jan 11:109953. doi: 10.1016/j.contraception.2023.109953.
    PubMed     Abstract available

  50. SCARSI KK, Smeaton LM, Podany AT, Olefsky M, et al
    Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens.
    Contraception. 2023 Jan 11:109951. doi: 10.1016/j.contraception.2023.109951.
    PubMed     Abstract available

  51. GUILLARD H, Laurora I, Sober S, Karapet A, et al
    Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S.
    Contraception. 2023;117:7-12.
    PubMed     Abstract available

  52. GLASIER A, Edelman A, Creinin MD, Brache V, et al
    The effect of deliberate non-adherence to a norgestrel progestin-only pill: A randomized, crossover study.
    Contraception. 2023;117:1-6.
    PubMed     Abstract available

  53. LEE CM, Johns SL, Stulberg DB, Allen RH, et al
    Barriers to abortion provision in primary care in New England, 2019-2020: A qualitative study.
    Contraception. 2023;117:39-44.
    PubMed     Abstract available

    December 2022
  54. CARVAJAL D, Bevilacqua KG, Caldwell MT, Zambrana RE, et al
    Provider Perspectives on Patient-Centered Contraceptive Counseling for Latinas in Baltimore, MD.
    Contraception. 2022 Dec 16:109921. doi: 10.1016/j.contraception.2022.109921.
    PubMed     Abstract available

  55. BLACK KI, Trane W, Dorney E, Mola G, et al
    Corrigendum to "A cross-sectional study of factors associated with immediate postpartum uptake of contraceptive implants in Papua New Guinea" [Contraception 117C Pages 25-29].
    Contraception. 2022 Dec 15:109918. doi: 10.1016/j.contraception.2022.109918.

  56. QURESHY Z, Lokken RP, Kakar S, Grab J, et al
    Influence of Progestin-only Hormonal Use on Hepatocellular Adenomas: A Retrospective Cohort Study.
    Contraception. 2022 Dec 4:S0010-7824(22)00439.
    PubMed     Abstract available

  57. LAI R
    "Every Medicine Is Somewhat Poisonous": Understanding the Reluctance to Use Oral Contraceptives Among Unmarried Women Seeking Abortion in China.
    Contraception. 2022 Dec 3:S0010-7824(22)00437.
    PubMed     Abstract available

  58. HARADA T, Ota I, Kitawaki J, Momoeda M, et al
    Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI).
    Contraception. 2022;116:22-28.
    PubMed     Abstract available

  59. REYNOLDS-WRIGHT JJ, Woldetsadik MA, Morroni C, Cameron ST, et al
    Pain management for medical abortion before 14 weeks' gestation: A systematic review.
    Contraception. 2022;116:4-13.
    PubMed     Abstract available

    November 2022
  60. STEINER RJ, McDonald-Mosley R
    Over-the-counter oral contraception in the United States: An important opportunity at a time of increased concern about contraceptive access.
    Contraception. 2022 Nov 28:109911. doi: 10.1016/j.contraception.2022.

  61. SATHAR Z, Singh S, Hussain S, Sadiq M, et al
    Contraception. 2022 Nov 26:S0010-7824(22)00433.
    PubMed     Abstract available

  62. HOLADAY LW, Gover M, Iyer SV, DeLuca JP, et al
    Effectiveness of training primary care internal medicine residents in etonogestrel implants and impact on their future practice: A cross-sectional study.
    Contraception. 2022;115:31-35.
    PubMed     Abstract available

  63. MANHART MD, Duane M
    A comparison of app-defined fertile days from two fertility tracking apps using identical cycle data.
    Contraception. 2022;115:12-16.
    PubMed     Abstract available

  64. KEMPPAINEN V, Mentula M, Palkama V, Heikinheimo O, et al
    Patient-controlled intravenous versus on-demand oral, intramuscular or mcs intravenous administration of oxycodone during medical induced abortion from 64 to 128 days of Gestation: A randomized controlled trial.
    Contraception. 2022;115:6-11.
    PubMed     Abstract available

  65. YOUNG D, Fitzgerald K, Laursen L, Whitaker AK, et al
    Comparison of vaginal and buccal misoprostol after mifepristone for medication abortion through 70 days of gestation: A retrospective chart review.
    Contraception. 2022;115:62-66.
    PubMed     Abstract available

    October 2022
  66. AVERBACH S, Johns NE, Ghule M, Dixit A, et al
    Understanding quality of contraceptive counseling in the CHARM2 gender-equity focused family planning intervention: findings from a cluster randomized controlled trial among couples in rural India.
    Contraception. 2022 Oct 31. pii: S0010-7824(22)00421.
    PubMed     Abstract available

  67. CHEN MJ, Jensen JT, Kaunitz AM, Achilles SL, et al
    Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials.
    Contraception. 2022 Oct 15. pii: S0010-7824(22)00395.
    PubMed     Abstract available

  68. BLACK KI, Trane W, Dorney E, Mola G, et al
    A cross-sectional study of factors associated with immediate postpartum uptake of contraceptive implants in Papua New Guinea.
    Contraception. 2022 Oct 14. pii: S0010-7824(22)00390.
    PubMed     Abstract available

  69. GOYAL S, Monsour M, Ko JY, Curtis KM, et al
    Contraception claims by medication for opioid use disorder prescription status among insured women with opioid use disorder, United States, 2018.
    Contraception. 2022 Oct 12. pii: S0010-7824(22)00389.
    PubMed     Abstract available

  70. HOLT K, Karp C, Uttekar BV, Quintero X, et al
    Reduction of the Quality of Contraceptive Counseling (QCC) Scale to a Short Version (QCC-10) in Ethiopia, India, and Mexico.
    Contraception. 2022 Oct 12. pii: S0010-7824(22)00383.
    PubMed     Abstract available

  71. HENLEY C, Jenner E, Richardson B, Falk G, et al
    Non-Barrier Contraceptive Use Patterns Among Latina Adolescents Attending California Reproductive Health Centers: A Longitudinal Study.
    Contraception. 2022 Oct 11:9897. doi: 10.1016/j.contraception.2022.
    PubMed     Abstract available

  72. KAPLAN J, Turok DK, Gero A, Kaiser JE, et al
    Switching and discontinuation of participant-masked randomization to a copper or levonorgestrel intrauterine device when presenting for emergency contraception.
    Contraception. 2022 Oct 11. pii: S0010-7824(22)00386.
    PubMed     Abstract available

  73. WIMSETT DJ, Legget E, Roberts DH, Oyston DC, et al
    Factors associated with postpartum contraceptive planning in New Zealand.
    Contraception. 2022 Oct 11. pii: S0010-7824(22)00387.
    PubMed     Abstract available

  74. CROWE J, Cohen R
    Infected myometrial hematoma due to malpositioned levonorgestrel intrauterine device: A case report.
    Contraception. 2022;114:85-88.
    PubMed     Abstract available

  75. MILES C, Weidner A, Summit AK, Thomson CJ, et al
    Patient opinions on sexual and reproductive health services in primary care in rural and urban clinics.
    Contraception. 2022;114:26-31.
    PubMed     Abstract available

  76. ROTHSCHILD CW, Richardson BA, Guthrie BL, Drake AL, et al
    Trajectories of method dissatisfaction among Kenyan women using modern, reversible contraception: A prospective cohort study.
    Contraception. 2022 Oct 1. pii: S0010-7824(22)00380.
    PubMed     Abstract available

    September 2022
  77. LEE JK, Gutin SA, Getahun M, Okiring J, et al
    Condom, modern contraceptive, and dual method use are associated with HIV status and relationship concurrency in a context of high mobility: A cross-sectional study of women of reproductive age in rural Kenya and Uganda, 2016.
    Contraception. 2022 Sep 14. pii: S0010-7824(22)00248.
    PubMed     Abstract available

  78. KANGASNIEMI MH, Arffman RK, Haverinen A, Luiro K, et al
    Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial.
    Contraception. 2022 Sep 6. pii: S0010-7824(22)00246.
    PubMed     Abstract available

  79. ENNIS M, Renner R, Guilbert E, Norman WV, et al
    Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey.
    Contraception. 2022;113:19-25.
    PubMed     Abstract available

  80. CLERMIDY H, Fabre D, Hugues JN, Alonso CG, et al
    Management of Etonogestrel implant migration into the pulmonary artery.
    Contraception. 2022;113:62-67.
    PubMed     Abstract available

    August 2022
  81. HANSEN K, Boniface ER, Darney BG
    Association of Title X clinic status with receipt of person-centered contraceptive counseling: a population-based study.
    Contraception. 2022 Aug 19. pii: S0010-7824(22)00222.
    PubMed     Abstract available

  82. SWAN LET, Vu H, Higgins JA, Bui LM, et al
    Exploring financial stress and resource deprivation as barriers to preferred contraceptive use in Wisconsin in 2021.
    Contraception. 2022 Aug 5. pii: S0010-7824(22)00220.
    PubMed     Abstract available

  83. CEULEMANS M, Willekens J, Cavens L, De Wulf I, et al
    Knowledge and counseling preferences of the public and pharmacy staff on emergency contraception: results of a cross-sectional study in Belgium.
    Contraception. 2022 Aug 3. pii: S0010-7824(22)00217.
    PubMed     Abstract available

  84. ROMERO D, Manze M, Roberts L, McGroarty A, et al
    Stakeholder perspectives in New York State on reproductive health and pregnancy intention screening in primary care: A qualitative study.
    Contraception. 2022;112:93-99.
    PubMed     Abstract available

  85. BRADFORD RD, Farnsworth SJ, Laurora I, Sober S, et al
    Adherence among a cohort taking progestin-only pills prescribed by a healthcare provider: Results of the BENCHMARK study.
    Contraception. 2022;112:48-53.
    PubMed     Abstract available

  86. WESTHOFF CL, Archer DF, Barnhart K, Darney P, et al
    Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens.
    Contraception. 2022;112:54-60.
    PubMed     Abstract available

  87. KOHN JE, Berlan ED, Tang JH, Beasley A, et al
    Society of Family Planning committee consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC).
    Contraception. 2022;112:11-13.
    PubMed     Abstract available

  88. HAN L, Creinin MD, Hemon A, Glasier A, et al
    Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception.
    Contraception. 2022;112:43-47.
    PubMed     Abstract available

  89. GLASIER A, Edelman A, Creinin MD, Han L, et al
    Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity.
    Contraception. 2022;112:37-42.
    PubMed     Abstract available

  90. MILES C, Ennamuri D, Yeh J, Shih G, et al
    Would you be interested in DMPA-SC? An implementation project in two urban primary care clinics.
    Contraception. 2022;112:116-119.
    PubMed     Abstract available

    July 2022
  91. KAUNITZ AM, Achilles SL, Zatik J, Weyers S, et al
    Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women.
    Contraception. 2022 Jul 31. pii: S0010-7824(22)00218.
    PubMed     Abstract available

  92. JENSEN JT, Kaunitz AM, Achilles SL, Zatik J, et al
    Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials.
    Contraception. 2022 Jul 31. pii: S0010-7824(22)00215.
    PubMed     Abstract available

  93. JONAS K, Lombard C, Chirinda W, Govindasamy D, et al
    Participation in an HIV prevention intervention and access to and use of contraceptives among young women: a cross sectional analysis in six South African districts.
    Contraception. 2022 Jul 23. pii: S0010-7824(22)00199.
    PubMed     Abstract available

  94. HASSELBACHER L, Moore A, Thompson L, Tyler CP, et al
    Exploring Illinois Contraceptive Providers' Interest in Medication Abortion Training.
    Contraception. 2022 Jul 20. pii: S0010-7824(22)00198.
    PubMed     Abstract available

  95. NGUYEN BT, Jacobsohn TL
    Post-abortion contraception, an opportunity for male partners and male contraception.
    Contraception. 2022 Jul 20. pii: S0010-7824(22)00195.
    PubMed     Abstract available

    June 2022
  96. TUMLINSON K, Britton LE, Williams CR, Wambua DM, et al
    Contraceptive method denial as downward contraceptive coercion: a mixed-methods mystery client study in Western Kenya.
    Contraception. 2022 Jun 29. pii: S0010-7824(22)00170.
    PubMed     Abstract available

  97. CLELAND K, Kumar B, Kakkad N, Shabazz J, et al
    Now Is the Time to Safeguard Access to Emergency Contraception Before Abortion Restrictions Sweep the United States.
    Contraception. 2022 Jun 23. pii: S0010-7824(22)00167.
    PubMed     Abstract available

  98. DETHIER D, Qasba N, Kaneshiro B
    Society of Family Planning Clinical Recommendation: Extended Use of Long Acting Reversible Contraception.
    Contraception. 2022 Jun 15. pii: S0010-7824(22)00162.
    PubMed     Abstract available

  99. MANCHIKANTI GOMEZ A, Rafie S, Garner-Ford E, Arcara J, et al
    Community Perspectives on Pharmacist-Prescribed Hormonal Contraception in Rural California.
    Contraception. 2022 Jun 4. pii: S0010-7824(22)00153.
    PubMed     Abstract available

  100. FRIEDLANDER EB, Raidoo S, Soon R, Salcedo J, et al
    The experience of pain in real-time during medication abortion.
    Contraception. 2022;110:71-75.
    PubMed     Abstract available

  101. WHITEHOUSE KC, Shochet T, Lohr PA
    Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation.
    Contraception. 2022;110:21-26.
    PubMed     Abstract available

  102. DUIJKERS IJM, Klipping C, Rautenberg T, Schug BS, et al
    Effect on ovarian activity and ovulation inhibition of different oral dosages of levonorgestrel.
    Contraception. 2022;110:6-15.
    PubMed     Abstract available

  103. CADDY C, Williams H, Hocking J, Coombe J, et al
    "I never went to see that doctor again": A qualitative study examining Australian women's experiences requesting removal of LARC within 12 months of insertion.
    Contraception. 2022;110:81-85.
    PubMed     Abstract available

    May 2022
  104. CREININ MD, Vieira CS, Westhoff CL, Mansour DJA, et al
    Recommendations for standardization of bleeding data analyses in contraceptive studies.
    Contraception. 2022 May 28. pii: S0010-7824(22)00152.
    PubMed     Abstract available

  105. WOODHAMS E, Samura T, White K, Patton E, et al
    Society of Family Planning Clinical Recommendations: Contraception and abortion care for persons who use substances.
    Contraception. 2022 May 26. pii: S0010-7824(22)00151.
    PubMed     Abstract available

  106. REED R, Osby O, Nelums M, Welchlin C, et al
    Contraceptive care experiences and preferences among Black women in Mississippi: A qualitative study.
    Contraception. 2022 May 26. pii: S0010-7824(22)00140.
    PubMed     Abstract available

  107. STIFANI BM, Madden T, Micks E, Moayedi G, et al
    Society of Family Planning Clinical Recommendations: Contraceptive Care in the Context of Pandemic Response.
    Contraception. 2022 May 17. pii: S0010-7824(22)00138.
    PubMed     Abstract available

  108. KOCH SK, Paul R, Addante AN, Brubaker A, et al
    Medicaid Reimbursement Program for Immediate Postpartum Long-Acting Reversible Contraception Improves Uptake Regardless of Insurance Status.
    Contraception. 2022 May 16. pii: S0010-7824(22)00137.
    PubMed     Abstract available

  109. AHMAD ZM, Noel NL, Rudd TM, Nadelson CS, et al
    Implementation of a Pharmacist-led Hormonal Contraceptive Prescribing Service in a Campus Community Pharmacy in Indiana, United States.
    Contraception. 2022 May 13. pii: S0010-7824(22)00133.
    PubMed     Abstract available

  110. SACK DE, Peetluk LS, Audet CM
    Couples-based interventions and postpartum contraceptive uptake: a systematic review.
    Contraception. 2022 May 13. pii: S0010-7824(22)00131.
    PubMed     Abstract available

  111. HELLWIG F, Ewerling F, Coll CVN, Barros AJD, et al
    The role of female permanent contraception in meeting the demand for family planning in low- and middle-income countries.
    Contraception. 2022 May 11. pii: S0010-7824(22)00135.
    PubMed     Abstract available

  112. JACOBSOHN T, Nguyen BT, Brown JE, Thirumalai A, et al
    Male Contraception is Coming: Who Do Men Want to Prescribe their Birth Control?
    Contraception. 2022 May 9. pii: S0010-7824(22)00132.
    PubMed     Abstract available

  113. MASTEN M, Larrea N, Schultz C, Lazorwitz A, et al
    Short-notice cancellations of laparoscopic permanent contraception.
    Contraception. 2022 May 8. pii: S0010-7824(22)00130.
    PubMed     Abstract available

  114. SOIN KS, Yeh PT, Gaffield ME, Ge C, et al
    Health workers' values and preferences regarding contraceptive methods globally: a systematic review.
    Contraception. 2022 May 5. pii: S0010-7824(22)00129.
    PubMed     Abstract available

  115. YEH PT, Kautsar H, Kennedy CE, Gaffield ME, et al
    Values and preferences for contraception: a global systematic review.
    Contraception. 2022 May 4. pii: S0010-7824(22)00128.
    PubMed     Abstract available

  116. ADASHI EY, Rajan RS, O'Mahony DP, Cohen IG, et al
    The next two decades of mifepristone at FDA: History as destiny().
    Contraception. 2022;109:1-7.
    PubMed     Abstract available

  117. RAZON N, Wulf S, Perez C, McNeil S, et al
    Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics,.
    Contraception. 2022;109:19-24.
    PubMed     Abstract available

  118. JARIENE K, Ulevicius J, Petrusaite A, Sirataviciene A, et al
    Sexual behavior of Lithuanian high school students.
    Contraception. 2022;109:62-67.
    PubMed     Abstract available

  119. BIGGS MA, Ralph L, Morris N, Ehrenreich K, et al
    A cross-sectional survey of U.S. abortion patients' interest in obtaining medication abortion over the counter.
    Contraception. 2022;109:25-31.
    PubMed     Abstract available

  120. FOSTER AM, Messier K, Aslam M, Shabir N, et al
    Community-based distribution of misoprostol for early abortion: Outcomes from a program in Sindh, Pakistan.
    Contraception. 2022;109:49-51.
    PubMed     Abstract available

  121. RUSSELL CB, Qasba N, Evans ML, Frankel A, et al
    Variation in the interpretation and application of the Medicaid sterilization consent form among Medicaid officials.
    Contraception. 2022;109:57-61.
    PubMed     Abstract available

  122. LAROCHE KJ, Wylie A, Persaud M, Foster AM, et al
    Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
    Contraception. 2022;109:37-42.
    PubMed     Abstract available

  123. BYRNE JJ, Smith EM, Saucedo AM, Doody KA, et al
    Accessibility to postpartum tubal ligation after a vaginal delivery: When the Medicaid policy is not a limiting factor.
    Contraception. 2022;109:52-56.
    PubMed     Abstract available

    April 2022
  124. MCCOOL-MYERS M, Kozlowski D, Jean V, Cordes S, et al
    The COVID-19 pandemic's impact on sexual and reproductive health in Georgia, USA: An exploration of behaviors, contraceptive care, and partner abuse.
    Contraception. 2022 Apr 27. pii: S0010-7824(22)00126.
    PubMed     Abstract available

  125. BURKE HM, Packer C, Fuchs R, Brache V, et al
    Acceptability of the contraceptive Sayana(R) Press when injected every four months: Results from a 12-month trial in Brazil, Chile and the Dominican Republic.
    Contraception. 2022 Apr 26. pii: S0010-7824(22)00124.
    PubMed     Abstract available

  126. STORCK KE, Gawron LM, Sanders JN, Wiaderny N, et al
    "I just had to pay the money and be supportive": A qualitative exploration of the male-partner role in contraceptive decision-making in Salt Lake City, Utah family planning clinics.
    Contraception. 2022 Apr 22. pii: S0010-7824(22)00109.
    PubMed     Abstract available

  127. MONIZ MH, Spector-Bagdady K, Perritt JB, Heisler M, et al
    Balancing Enhanced Contraceptive Access with Risk of Reproductive Injustice: A United States Comparative Case Study.
    Contraception. 2022 Apr 16. pii: S0010-7824(22)00105.
    PubMed     Abstract available

  128. MANZER JL, Berndt VK, Bell AV
    Comparing methods of long-acting reversible contraception: A qualitative study of Delaware women's perceptions of intrauterine devices and the implant.
    Contraception. 2022 Apr 10. pii: S0010-7824(22)00104.
    PubMed     Abstract available

  129. HARGRAVE AS, Ong A, Raza Z, Franco C, et al
    Opportunities for improving provision of emergency contraception in California.
    Contraception. 2022 Apr 2. pii: S0010-7824(22)00102.
    PubMed     Abstract available

  130. LEROY L, West AM, Hall C, Thomas D, et al
    A Real-World Comparison of In-Person vs. Virtual Contraceptive Care Trainings for Clinicians and Support Staff.
    Contraception. 2022 Apr 1. pii: S0010-7824(22)00082.
    PubMed     Abstract available

  131. RODRIGUEZ MI, Skye M, Samandari G, Darney BG, et al
    Timing of postpartum long acting, reversible contraception was not associated with 12-month removal rates in a large Medicaid sample.
    Contraception. 2022 Apr 1. pii: S0010-7824(22)00080.
    PubMed     Abstract available

  132. GILBERT AL, Amico JR
    Dilation and evacuation with an abdominal cerclage at 21 weeks gestation: A case report.
    Contraception. 2022;108:78-79.
    PubMed     Abstract available

  133. DRAGOMAN M, Fofie C, Bergen S, Chavkin W, et al
    Integrating self-managed medication abortion with medical care.
    Contraception. 2022;108:1-3.
    PubMed     Abstract available

    March 2022
  134. WU JP, Johnson E, Taichman LS
    Contraceptive decisions among individuals with medical conditions in Michigan, USA: A qualitative explanatory model informed by the Health Belief Model and the principle of respect for patient autonomy.
    Contraception. 2022 Mar 26. pii: S0010-7824(22)00084.
    PubMed     Abstract available

  135. MELBOSTAD HS, Wachtel DS, Lipke KA, Badger GJ, et al
    Preliminary Side Effect Profile, Safety, and Tolerability of Hormonal Contraception Among Women Receiving Opioid-Agonist Therapy.
    Contraception. 2022 Mar 10. pii: S0010-7824(22)00061.
    PubMed     Abstract available

  136. HURTADO ACM, Crowley SM, Landry KM, Landry MS, et al
    Telehealth Contraceptive Care in 2018: A Quality Improvement Study of Barriers to Access and Patient Satisfaction.
    Contraception. 2022 Mar 6. pii: S0010-7824(22)00059.
    PubMed     Abstract available

  137. ELIASON EL, Spishak-Thomas A, Steenland MW
    Title: Association of the Affordable Care Act Medicaid Expansions with Postpartum Contraceptive Use and Early Postpartum Pregnancy.
    Contraception. 2022 Mar 5. pii: S0010-7824(22)00060.
    PubMed     Abstract available

    Healthcare Access and Contraceptive Use among Adult Women in the United States in 2017.
    Contraception. 2022 Mar 3. pii: S0010-7824(22)00056.
    PubMed     Abstract available

  139. SHIN RJ, Yao M, Akesson C, Blazel M, et al
    An exploratory study comparing the quality of contraceptive counseling provided via telemedicine versus in-person visits.
    Contraception. 2022 Mar 2. pii: S0010-7824(22)00053.
    PubMed     Abstract available

  140. DOAN YP, Lehman EB, Chuang CH
    Effect of Neighborhood-Level Income on Access to Emergency Contraception.
    Contraception. 2022 Mar 2. pii: S0010-7824(22)00054.
    PubMed     Abstract available

  141. WIMSETT DJ, Sadler DL, Tutty DS, Tutty DE, et al
    Pregnancy planning and barriers to accessing postnatal contraception in New Zealand.
    Contraception. 2022 Mar 2. pii: S0010-7824(22)00055.
    PubMed     Abstract available

  142. UHM S, Mastey N, Baker CC, Chen MJ, et al
    Mifepristone prior to osmotic dilators for dilation and evacuation cervical preparation: A randomized, double-blind, placebo-controlled pilot study.
    Contraception. 2022;107:23-28.
    PubMed     Abstract available

  143. GROSSMAN D, Raifman S, Morris N, Arena A, et al
    Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment.
    Contraception. 2022;107:36-41.
    PubMed     Abstract available

  144. SHAY RL, Benson LS, Lokken EM, Micks EA, et al
    Same-day mifepristone prior to second-trimester induction termination with misoprostol: A retrospective cohort study.
    Contraception. 2022;107:29-35.
    PubMed     Abstract available

    February 2022
  145. DEHINGIA N, Barker KM, Raj A
    Relationship between adolescent friendship networks and contraceptive use and unintended pregnancies in early adulthood in the United States.
    Contraception. 2022 Feb 21. pii: S0010-7824(22)00032.
    PubMed     Abstract available

    The FDA ought to change Plan B's label.
    Contraception. 2022;106:6-9.
    PubMed     Abstract available

  147. CREININ M, Kohn JE, Tang JH, Serna TB, et al
    Society of Family Planning Committee statement on IUD nomenclature.
    Contraception. 2022;106:1-2.

    January 2022
  148. KUMNICK A, Hanfling SN, Dowlut-McElroy T, Maher JY, et al
    An Intersectional Analysis of Contraceptive Types Chosen Among Sexual Minority Women: A Nationally Representative Study.
    Contraception. 2022 Jan 24. pii: S0010-7824(22)00009.
    PubMed     Abstract available

  149. KAKAR V, Kulkarni A, Holschuh C, Smirnova A, et al
    Contraception Information on the Websites of Student Health Centers in the United States.
    Contraception. 2022 Jan 24. pii: S0010-7824(22)00011.
    PubMed     Abstract available

  150. LERMA K, McBrayer A, Nathan S, Dehlendorf C, et al
    Use of a contraceptive decision support tool in the abortion care setting.
    Contraception. 2022 Jan 23. pii: S0010-7824(22)00010.
    PubMed     Abstract available

  151. ENDLER M, Li R, Gemzell-Danielsson K
    Effect of levonorgestrel emergency contraception on implantation and fertility: a review.
    Contraception. 2022 Jan 23. pii: S0010-7824(22)00006.
    PubMed     Abstract available

  152. THORMAN A, Engle A, Brintz B, Simmons RG, et al
    Quantitative and qualitative impact of One Key Question(R) on primary care providers' contraceptive counseling at routine preventive health visits.
    Contraception. 2022 Jan 14. pii: S0010-7824(22)00003.
    PubMed     Abstract available

  153. KAMUYANGO A, Yu T, Ao CK, Hu SC, et al
    The public-sector family planning program impact scores in association with long acting reversible contraceptive use among young women in 22 Sub-Saharan African countries; A pooled multi-level analysis.
    Contraception. 2022 Jan 11. pii: S0010-7824(21)00497.
    PubMed     Abstract available

  154. WALLACE R, Shih G
    Complex family planning - Demarginalizing abortion care requires uplifting primary care and non-CFP providers.
    Contraception. 2022;105:86.

  155. SINKEY RG, Blanchard CT, Maier J, Novara A, et al
    The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease.
    Contraception. 2022;105:55-60.
    PubMed     Abstract available

  156. GLASIER A, Sober S, Gasloli R, Goyal A, et al
    A review of the effectiveness of a progestogen-only pill containing norgestrel 75 microg/day.
    Contraception. 2022;105:1-6.
    PubMed     Abstract available

    December 2021
  157. LAZORWITZ A, Sheeder J, Teal S
    Variability in repeat serum etonogestrel concentrations among contraceptive implant users during the steady-release pharmacokinetic period.
    Contraception. 2021 Dec 29. pii: S0010-7824(21)00463.
    PubMed     Abstract available

  158. RODRIGUEZ MI, Skye M, Ramanadhan S, Schrote K, et al
    Examining the association between short interpregnancy interval births and the type and timing of postpartum long acting reversible contraception.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00475.
    PubMed     Abstract available

  159. THOMPSON RL, Hu J, Custodio P, Dart C, et al
    The use of serum segesterone acetate levels to assess adherence of trial participants with a contraceptive vaginal ring.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00477.
    PubMed     Abstract available

  160. MANN ES, Chen AM, Johnson CL
    Doctor Knows Best? Provider Bias in the Context of Contraceptive Counseling in the United States.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00472.
    PubMed     Abstract available

  161. CHRISTINE BE, Rose M, Victoria Z, P H, et al
    Comparing perceptions of long-acting reversible contraception among women during periods of incarceration and women attending a local clinic; an exploratory study.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00480.
    PubMed     Abstract available

  162. KAWATU J, Clark M, Saul K, Quimby KD, et al
    Increasing access to single-visit contraception in urban health care settings: Findings from a multi-site learning collaborative.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00465.
    PubMed     Abstract available

  163. ROLAND N, Drouin J, Desplas D, Duranteau L, et al
    Impact of Coronavirus Disease 2019 (COVID-19) On Contraception Use in 2020 and up until the end of April 2021 in France.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00464.
    PubMed     Abstract available

  164. CHALMIERS MA, Karaki F, Muriki M, Mody S, et al
    Refugee women's experiences with contraceptive care after resettlement in high-income countries: A Critical Interpretive Synthesis.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00466.
    PubMed     Abstract available

  165. FOSTER DG, Gould H, Biggs MA
    Timing of pregnancy discovery among women seeking abortion().
    Contraception. 2021;104:642-647.
    PubMed     Abstract available

  166. ANGER HA, Raymond EG, Grant M, Haskell S, et al
    Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.
    Contraception. 2021;104:659-665.
    PubMed     Abstract available

  167. SHERPA LY, Tinkari BS, Gentle P, Sah RK, et al
    A prospective cohort study to assess the acceptability of Sayana Press among 18-49-year-old women in Nepal.
    Contraception. 2021;104:623-627.
    PubMed     Abstract available

    November 2021
  168. BEESHAM I, Bosman S, Beksinska M, Scoville CW, et al
    Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
    Contraception. 2021 Nov 27. pii: S0010-7824(21)00447.
    PubMed     Abstract available

  169. BERGLIN M, Stram D, Stenquist A, Dessi S, et al
    Contraception. 2021 Nov 27. pii: S0010-7824(21)00448.
    PubMed     Abstract available

  170. ANASTASIOU E, McCarthy KJ, Gollub EL, Ralph L, et al
    The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: a systematic review.
    Contraception. 2021 Nov 6. pii: S0010-7824(21)00445.
    PubMed     Abstract available

  171. WONG ZJ, Thompson L, Boulware A, Chen J, et al
    What You Don't Know Can Hurt You: Patient and Provider Perspectives on Postpartum Contraceptive Care in Illinois Catholic Hospitals.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00437.
    PubMed     Abstract available

  172. LI R, Ellington SR, Galang RR, Grosse SD, et al
    Economic evaluation of Zika Contraception Access Network in Puerto Rico during the 2016-17 Zika virus outbreak.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00440.
    PubMed     Abstract available

  173. LUNDBERG BR, Tabuyo-Martin A, Ponzini MD, Wilson MD, et al
    Contraceptive plans before pre-operative assessment and at procedure in surgical abortion patients.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00444.
    PubMed     Abstract available

  174. JARUAMORNJIT Y, Kaewrudee S, Sothornwit J
    Differences in postpartum contraceptive choices and patterns following low- and high-risk pregnancy.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00442.
    PubMed     Abstract available

  175. HOPKINS K, Remington C, Eilers MA, Rivas SD, et al
    Obtaining buy-in for immediate postpartum long-acting reversible contraception programs in Texas hospitals: A qualitative study.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00434.
    PubMed     Abstract available

  176. SALEEM HT, Rosen JG, Quinn C, Duggaraju A, et al
    Contraception values and preferences of people living with HIV: a systematic review.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00433.
    PubMed     Abstract available

  177. DAM A, Yeh PT, Burke AE, Kennedy CE, et al
    Contraceptive values and preferences of pregnant women, postpartum women, women seeking emergency contraceptives, and women seeking abortion services: a systematic review.
    Contraception. 2021 Nov 3. pii: S0010-7824(21)00439.
    PubMed     Abstract available

  178. NIU F, Cornelius J, Aboubechara N, Saraj A, et al
    Real world outcomes related to providing an annual supply of short-acting hormonal contraceptives.
    Contraception. 2021 Nov 3. pii: S0010-7824(21)00435.
    PubMed     Abstract available

  179. EL-HADAD S, Villars P, Kahr MK, Leeners B, et al
    Removal of nonpalpable etonogestrel implants after fixation with a curved needle-A case series().
    Contraception. 2021;104:577-580.
    PubMed     Abstract available

  180. WHITE AL, Mann ES, Billings DL, Shah P, et al
    A qualitative exploration of men's perceptions of the terms "male sterilization" versus "vasectomy" in the southern United States.
    Contraception. 2021;104:524-530.
    PubMed     Abstract available

  181. GLASER K, Fix M, Karlin J, Schwarz EB, et al
    Awareness of the option of IUC self-removal among US adolescents.
    Contraception. 2021;104:567-570.
    PubMed     Abstract available

  182. HORGAN P, Thompson M, Harte K, Gee R, et al
    Termination of pregnancy services in Irish general practice from January 2019 to June 2019.
    Contraception. 2021;104:502-505.
    PubMed     Abstract available

    October 2021
  183. KWAL J, Maguire K, Carugno J
    Localization and Management of Nonpalpable Radiopaque Contraceptive Implant.
    Contraception. 2021 Oct 11. pii: S0010-7824(21)00412.

  184. JIAQI X, Shuxian W, Linlin Y, Li L, et al
    Does China's universal two-child policy affect contraceptive use among internal migrant women in China? Evidence based on panel data.
    Contraception. 2021 Oct 6. pii: S0010-7824(21)00404.
    PubMed     Abstract available

  185. DIMENSTEIN NB, Lindberg LD, Arrington-Sanders R, Jennings JM, et al
    Exploring experience of and engagement in coercive pregnancy behaviors among sexually active young men from five clinics in Baltimore, MD.
    Contraception. 2021;104:367-371.
    PubMed     Abstract available

  186. CHATROUX L, Darney BG, Skye M, Caughey AB, et al
    Examining the effect of unintended pregnancy on health utility using four measures.
    Contraception. 2021;104:344-349.
    PubMed     Abstract available

  187. ROE AH, McAllister A, Flynn AN, Martin B, et al
    The effect of mifepristone pretreatment on bleeding and pain during medical management of early pregnancy loss.
    Contraception. 2021;104:432-436.
    PubMed     Abstract available

  188. KLANGSIN S, Suwanrath C, Wattanakumtornkul S
    A case report of eosinophilia associated with an etonogestrel implant.
    Contraception. 2021;104:442-443.
    PubMed     Abstract available

    September 2021
  189. KAPLAN S, Bertoia ML, Wang FT, Zhou L, et al
    Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States.
    Contraception. 2021 Sep 29. pii: S0010-7824(21)00406.
    PubMed     Abstract available

  190. RAINE-BENNETT T, Fassett MJ, Chandra M, Armstrong MA, et al
    Ectopic Pregnancy Prevention: Further Evidence of Benefits of Prescription Contraceptives.
    Contraception. 2021 Sep 18. pii: S0010-7824(21)00383.
    PubMed     Abstract available

  191. TEBB KP, Dehlendorf C, Rodriguez F, Fix M, et al
    Promoting Teen-to-Teen Contraceptive Communication with the SpeakOut Intervention, a Cluster Randomized Trial.
    Contraception. 2021 Sep 11. pii: S0010-7824(21)00377.
    PubMed     Abstract available

  192. BRINGLEY J, Zu V, Javlekar A, Daoud-Yilmaz F, et al
    Effects of Rotating at a Catholic Hospital on Medical Student Contraceptive Objective Structured Clinical Exam Scores.
    Contraception. 2021 Sep 7. pii: S0010-7824(21)00378.
    PubMed     Abstract available

  193. FURLAN RM, Garcia E, Castro S, Machado HC, et al
    Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception.
    Contraception. 2021 Sep 5. pii: S0010-7824(21)00374.
    PubMed     Abstract available

  194. SILVERSTEIN RG, Fitz V, Thornton M, Carter A, et al
    Contraceptive use and counseling in patients with systemic lupus erythematosus.
    Contraception. 2021 Sep 4. pii: S0010-7824(21)00376.
    PubMed     Abstract available

  195. SHELEF DQ, Raine-Bennett T, Chandra M, Adler N, et al
    The association between depression and contraceptive behaviors in a diverse sample of new prescription contraception users.
    Contraception. 2021 Sep 2. pii: S0010-7824(21)00373.
    PubMed     Abstract available

  196. FOK WK, Lerma K, Shaw KA, Blumenthal PD, et al
    Comparison of two home pregnancy tests for self-confirmation of medication abortion status: A randomized trial.
    Contraception. 2021;104:296-300.
    PubMed     Abstract available

    August 2021
  197. DIAMOND-SMITH N, Logan R, Marshall C, Corbetta-Rastelli C, et al
    COVID-19's impact on contraception experiences: exacerbation of structural inequities in women's health.
    Contraception. 2021 Aug 27. pii: S0010-7824(21)00369.
    PubMed     Abstract available

  198. ROE AH, Lang B, McAllister A, Gaitors MC, et al
    Contraceptive use and preferences among females with sickle cell disease.
    Contraception. 2021 Aug 18. pii: S0010-7824(21)00353.
    PubMed     Abstract available

  199. KREITCHMANN R, Stek A, Best BM, Capparelli E, et al
    Interactions Between Etonogestrel-Releasing Contraceptive Implant and Three Antiretroviral Regimens.
    Contraception. 2021 Aug 15. pii: S0010-7824(21)00350.
    PubMed     Abstract available

  200. STEENLAND MW, Geiger CK, Chen L, Rokicki S, et al
    Declines in Contraceptive Visits in the United States during the COVID-19 Pandemic.
    Contraception. 2021 Aug 14. pii: S0010-7824(21)00347.
    PubMed     Abstract available

  201. THOMPSON K, Kirschner JH, Irwin S, Lee A, et al
    Perceptions of Long-acting Reversible Contraception among Women in an Urban U.S. Jail.
    Contraception. 2021 Aug 13. pii: S0010-7824(21)00345.
    PubMed     Abstract available

  202. PAN YL, Beal L, Espino K, Sufrin CB, et al
    Female Permanent Contraception Policies and Occurrence at a Sample of U.S. Prisons and Jails.
    Contraception. 2021 Aug 13. pii: S0010-7824(21)00349.
    PubMed     Abstract available

  203. BROUSSARD K, Becker A
    Self-removal of long-acting reversible contraception: A content analysis of YouTube videos.
    Contraception. 2021 Aug 13. pii: S0010-7824(21)00346.
    PubMed     Abstract available

    Ethinyl estradiol and levonorgestrel patch phase 3 data clarification.
    Contraception. 2021;104:216.

  205. NELSON AL
    Author response to ethinyl estradiol and levonorgestrel Phase 3 data clarification.
    Contraception. 2021;104:217.

  206. LATACK KR, Patel J, Moog D, Spencer D, et al
    Withdrawal method inquiries and user experiences: An analysis of content posted on 4 gendered forums on Reddit.
    Contraception. 2021;104:170-175.
    PubMed     Abstract available

    July 2021
  207. AHRENS K, Skjeldestad FE
    Trends in initiation of hormonal contraceptive methods among teenagers born between 1989 and 1997 in Norway and the United States.
    Contraception. 2021 Jul 27. pii: S0010-7824(21)00339.
    PubMed     Abstract available

  208. WILKINSON TA, Edmonds BT, Cheng ER
    Outcomes of a Two-Visit Protocol for Long Acting Reversible Contraception for Adolescents and Young Adults.
    Contraception. 2021 Jul 27. pii: S0010-7824(21)00341.
    PubMed     Abstract available

  209. BROWN HK, Aker A, Wanigaratne S
    Multimorbidity and use of reversible contraception: Results from a Canadian cross-sectional survey.
    Contraception. 2021 Jul 27. pii: S0010-7824(21)00343.
    PubMed     Abstract available

  210. HARRISON MS, Jimenez-Zambrano A, Rivera C, Bunge-Montes S, et al
    Delivery of home-based postpartum contraception in Southwest Trifinio, Guatemala: reach, adoption, and implementation in a cluster-randomized trial.
    Contraception. 2021 Jul 13. pii: S0010-7824(21)00223.
    PubMed     Abstract available

  211. BARBOSA RM, Kalckmann S, Arilha M, Giacomodo Lago TD, et al
    The emergency contraceptive pill in Brazil: high usage rates but schooling differences persist.
    Contraception. 2021 Jul 2. pii: S0010-7824(21)00219.
    PubMed     Abstract available

  212. RODRIGUEZ MI, Meath T, Huang J, Darney BG, et al
    Association of rural location and long acting reversible contraceptive use among Oregon Medicaid recipients.
    Contraception. 2021 Jul 2. pii: S0010-7824(21)00218.
    PubMed     Abstract available

  213. DOHM J, Ji M
    An introduction to risk evaluation and mitigation strategies.
    Contraception. 2021;104:4-7.

  214. MARK A, Foster AM, Perritt J
    The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States.
    Contraception. 2021;104:38-42.
    PubMed     Abstract available

    Abortion exceptionalism and the mifepristone REMS.
    Contraception. 2021;104:8-11.
    PubMed     Abstract available

  216. KERESTES C, Murayama S, Tyson J, Natavio M, et al
    Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
    Contraception. 2021;104:49-53.
    PubMed     Abstract available

  217. CHONG E, Shochet T, Raymond E, Platais I, et al
    Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.
    Contraception. 2021;104:43-48.
    PubMed     Abstract available

  218. CLELAND K, Foster AM, Gomez AM, Raymond EG, et al
    Contraception Special Issue on the mifepristone Risk Evaluation and Mitigation Strategy (REMS).
    Contraception. 2021;104:1-3.

  219. THOMPSON A, Singh D, Ghorashi AR, Donovan MK, et al
    The disproportionate burdens of the mifepristone REMS.
    Contraception. 2021;104:16-19.

  220. MEURICE ME, Whitehouse KC, Blaylock R, Chang JJ, et al
    Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks' gestation at British Pregnancy Advisory Service: A cross-sectional evaluation.
    Contraception. 2021;104:61-66.
    PubMed     Abstract available

  221. STONE RH, Rafie S
    Medication abortion: Advocating for mifepristone dispensing by pharmacists.
    Contraception. 2021;104:31-32.

  222. KAYE J, Reeves R, Chaiten L
    The mifepristone REMS: A needless and unlawful barrier to care.
    Contraception. 2021;104:12-15.
    PubMed     Abstract available

  223. SRINIVASULU S, Yavari R, Brubaker L, Riker L, et al
    US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.
    Contraception. 2021;104:92-97.
    PubMed     Abstract available

  224. CALLOWAY D, Stulberg DB, Janiak E
    Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States.
    Contraception. 2021;104:24-28.
    PubMed     Abstract available

  225. RAIDOO S, Kaneshiro B, Stowers P
    Guam: The US territory where America's day begins but abortion access is still in the dark.
    Contraception. 2021;104:33-35.
    PubMed     Abstract available

  226. GLASER K, Whitehair J
    Missing mifepristone at tribal health facilities serving native Americans.
    Contraception. 2021;104:36-37.
    PubMed     Abstract available

  227. DANIEL S, Schulkin J, Grossman D
    Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone.
    Contraception. 2021;104:73-76.
    PubMed     Abstract available

  228. RASMUSSEN KN, Janiak E, Cottrill AA, Stulberg DB, et al
    Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois.
    Contraception. 2021;104:98-103.
    PubMed     Abstract available

    June 2021
  229. FAY KE, Clement AC, Gero A, Kaiser JE, et al
    Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: implications for backup contraception recommendations.
    Contraception. 2021 Jun 21. pii: S0010-7824(21)00210.
    PubMed     Abstract available

  230. BRACHE V, Vieira CS, Plagianos M, Lansiaux M, et al
    Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: a randomized proof-of-concept study.
    Contraception. 2021 Jun 19. pii: S0010-7824(21)00193.
    PubMed     Abstract available

  231. NGUYEN BT, Yuen F, Farrant M, Thirumalai A, et al
    Acceptability of the oral hormonal male contraceptive prototype, 11beta-Methyl-19-nortestosterone dodecylcarbonate (11beta-MNTDC), in a 28-day placebo-controlled trial.
    Contraception. 2021 Jun 18. pii: S0010-7824(21)00192.
    PubMed     Abstract available

  232. LAVELANET AF, Ralph JA, Ti A, Duggaraju A, et al
    A systematic review exploring the contraception values and preferences of sex workers, transmasculine individuals, people who inject drugs, and those living in humanitarian contexts.
    Contraception. 2021 Jun 18. pii: S0010-7824(21)00191.
    PubMed     Abstract available

  233. LEW J, Sheeder J, Lazorwitz A
    Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients.
    Contraception. 2021 Jun 17. pii: S0010-7824(21)00190.
    PubMed     Abstract available

  234. ZEAL C, Paul R, Dorsey M, Politi MC, et al
    Young women's preferences for contraceptive education: the importance of the clinician.
    Contraception. 2021 Jun 14. pii: S0010-7824(21)00188.
    PubMed     Abstract available

  235. NGUYEN BT, Brown AL, Jones F, Jones L, et al
    "I'm not going to be a guinea pig:" medical mistrust as a barrier to male contraception for Black American men in Los Angeles, CA.
    Contraception. 2021 Jun 9. pii: S0010-7824(21)00184.
    PubMed     Abstract available

  236. GYLLENBERG F, Tekay A, Saloranta T, Korjamo R, et al
    Contraception. 2021 Jun 9. pii: S0010-7824(21)00186.
    PubMed     Abstract available

  237. SOBEL L, Lee YW, White KO, Woodhams E, et al
    Contraceptive decision making among pregnancy-capable individuals with opioid use disorder at a tertiary care center in Massachusetts.
    Contraception. 2021 Jun 9. pii: S0010-7824(21)00185.
    PubMed     Abstract available

  238. RODRIGUEZ MI, Kaufman M, Manibusan B, Anderson L, et al
    Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist.
    Contraception. 2021 Jun 8. pii: S0010-7824(21)00187.
    PubMed     Abstract available

  239. LIN TK, Law R, Beaman J, Foster DG, et al
    The impact of the COVID-19 pandemic on economic security and pregnancy intentions among people at risk of pregnancy.
    Contraception. 2021;103:380-385.
    PubMed     Abstract available

  240. GILLIAM ML, Jensen JT, Eisenberg DL, Thomas MA, et al
    Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years.
    Contraception. 2021;103:444-449.
    PubMed     Abstract available

  241. RAYMOND EG, Anger HA, Chong E, Haskell S, et al
    "False positive" urine pregnancy test results after successful medication abortion.
    Contraception. 2021;103:400-403.
    PubMed     Abstract available

  242. FLYNN AN, Roe AH, Koelper N, McAllister A, et al
    Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss.
    Contraception. 2021;103:404-407.
    PubMed     Abstract available

    May 2021
  243. RIVAS K, Schmuhl NB, Taboada M, Godecker A, et al
    Are Wisconsin resident physicians trained in immediate postpartum long acting reversible contraception?
    Contraception. 2021 May 31. pii: S0010-7824(21)00176.
    PubMed     Abstract available

  244. GOYAL V, Madison AM, Powers DA, Potter JE, et al
    Impact of Contraceptive Counseling on Texans Who Can and Cannot Receive No-Cost Post-Abortion Contraception.
    Contraception. 2021 May 30. pii: S0010-7824(21)00178.
    PubMed     Abstract available

  245. TI A, Soin K, Rahman T, Dam A, et al
    Contraceptive values and preferences of adolescents and young adults: a systematic review.
    Contraception. 2021 May 30. pii: S0010-7824(21)00179.
    PubMed     Abstract available

  246. KRAMER RD, Higgins JA, Burns ME, Stulberg DB, et al
    Expectations about Availability of Contraception and Abortion at a Hypothetical Catholic Hospital: Rural-Urban Disparities among Wisconsin Women.
    Contraception. 2021 May 28. pii: S0010-7824(21)00175.
    PubMed     Abstract available

  247. LASSAR M, Tao K, Bond T, Qadir S, et al
    Closing the contraceptive coverage gap: a multi-pronged approach to advancing reproductive equity in Illinois.
    Contraception. 2021 May 27. pii: S0010-7824(21)00157.
    PubMed     Abstract available

  248. KHIN YP, Nawa N, Fujiwara T, Surkan PJ, et al
    Access to contraceptive services among Myanmar women living in Japan: A qualitative study.
    Contraception. 2021 May 26. pii: S0010-7824(21)00155.
    PubMed     Abstract available

  249. SONG B, White VanGompel E, Wang C, Guzman S, et al
    Corrigendum to "Effects of Clinic-level Implementation of One Key Question(R) on Reproductive Health Counseling and Patient Satisfaction" [Contraception 103 (2021): 6-12].
    Contraception. 2021 May 25. pii: S0010-7824(21)00113.

  250. VEGA A, Choi YJ, Tschann M, Salcedo J, et al
    Over-the-Counter Access to Levonorgestrel Emergency Contraception in South Texas: Does Over-the-Counter Mean Ready to Buy?
    Contraception. 2021 May 21. pii: S0010-7824(21)00152.
    PubMed     Abstract available

  251. GIFFORD K, McDuffie MJ, Rashid H, Knight EK, et al
    Postpartum contraception method type and risk of a short inter-pregnancy interval in a state Medicaid population.
    Contraception. 2021 May 20. pii: S0010-7824(21)00153.
    PubMed     Abstract available

  252. CREININ MD, Westhoff CL, Bouchard C, Chen MJ, et al
    Estetrol-Drospirenone Combination Oral Contraceptive: North American Phase 3 Efficacy and Safety Results.
    Contraception. 2021 May 14. pii: S0010-7824(21)00149.
    PubMed     Abstract available

  253. KEOGH SC, Otupiri E, Castillo PW, Chiu DW, et al
    Hormonal contraceptive use in Ghana: the role of method attributes and side effects in method choice and continuation.
    Contraception. 2021 May 13. pii: S0010-7824(21)00151.
    PubMed     Abstract available

    April 2021
  254. COMFORT AB, Harper CC, Tsai AC, Moody J, et al
    Social and provider networks and women's contraceptive use: Evidence from Madagascar.
    Contraception. 2021 Apr 23. pii: S0010-7824(21)00129.
    PubMed     Abstract available

  255. ARIYO O, Khoury AJ, Smith MG, Leinaar E, et al
    From Training to Implementation: Improving Contraceptive Practices in South Carolina.
    Contraception. 2021 Apr 21. pii: S0010-7824(21)00132.
    PubMed     Abstract available

  256. DEV R, Kohler P, Begnel E, Achwoka D, et al
    Contraceptive counseling experiences among women attending HIV Care and Treatment Centers: a national survey in Kenya.
    Contraception. 2021 Apr 21. pii: S0010-7824(21)00127.
    PubMed     Abstract available

  257. STIFANI BM, Smith A, Avila K, Boos EW, et al
    Telemedicine for contraceptive counseling: patient experiences during the early phase of the Covid-19 pandemic in New York City.
    Contraception. 2021 Apr 13. pii: S0010-7824(21)00111.
    PubMed     Abstract available

  258. HUBER-KRUM S, Bornstein M, Garver S, Gipson J, et al
    Are rural Malawian women using their preferred contraceptive method and that of their male partners?
    Contraception. 2021 Apr 3. pii: S0010-7824(21)00100.
    PubMed     Abstract available

  259. BOUMA-JOHNSTON H, Ponsaran R, Arora KS
    Variation by state in Medicaid sterilization policies for physician reimbursement.
    Contraception. 2021;103:255-260.
    PubMed     Abstract available

    March 2021
  260. LIU JH, Plagianos M, Archer DF, Simon JA, et al
    Segesterone Acetate Serum Levels with a Regression Model of Continuous Use of the Segesterone Acetate/Ethinyl Estradiol Contraceptive Vaginal System.
    Contraception. 2021 Mar 27. pii: S0010-7824(21)00096.
    PubMed     Abstract available

  261. HADDAD LB, RamaRao S, Hazra A, Birungi H, et al
    Addressing contraceptive needs exacerbated by COVID-19: A call for increasing choice and access to self-managed methods.
    Contraception. 2021 Mar 26. pii: S0010-7824(21)00095.
    PubMed     Abstract available

  262. BONIFACE ER, Rodriguez MI, Heintzman J, Knipper S, et al
    Contraceptive provision in Oregon School-Based Health Centers: Method type trends and the role of Title X.
    Contraception. 2021 Mar 26. pii: S0010-7824(21)00092.
    PubMed     Abstract available

  263. BREWER M, Stevens L
    Use of Fertility Awareness-Based Methods of Contraception: Evidence from the National Survey of Family Growth, 2013-17.
    Contraception. 2021 Mar 21. pii: S0010-7824(21)00086.
    PubMed     Abstract available

  264. SKRACIC I, Lewin AB, Roy KM
    Evaluation of the Delaware Contraceptive Access Now (DelCAN) initiative: A qualitative analysis of site leaders' implementation recommendations.
    Contraception. 2021 Mar 21. pii: S0010-7824(21)00087.
    PubMed     Abstract available

  265. TEBB KP, Rodriguez F, Pollack LM, Adams S, et al
    Improving Contraceptive Use Among Latina Adolescents: A Cluster-Randomized Controlled Trial Evaluating an mHealth Application, Health-E You/Salud iTu.
    Contraception. 2021 Mar 17. pii: S0010-7824(21)00059.
    PubMed     Abstract available

  266. DUIJKERS I, Klipping C, Kinet V, Jost M, et al
    Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function.
    Contraception. 2021 Mar 6. pii: S0010-7824(21)00058.
    PubMed     Abstract available

  267. GAFFIELD ME, Kiarie J
    Setting global standards: The paramount importance of considering contraceptive values and preferences of clients and providers.
    Contraception. 2021 Mar 5. pii: S0010-7824(18)30399.

    Contraceptive counseling following in-clinic pregnancy test among women not expecting pregnancy in the next two years: Disparities by service delivery setting and sociodemographic characteristics.
    Contraception. 2021 Mar 2. pii: S0010-7824(21)00055.
    PubMed     Abstract available

  269. DRAGOMAN MV, Grossman D, Nguyen MH, Habib N, et al
    Two prophylactic pain management regimens for medical abortion
    Contraception. 2021;103:163-170.
    PubMed     Abstract available

  270. NELSON AL, Kaunitz AM, Kroll R, Simon JA, et al
    Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results.
    Contraception. 2021;103:137-143.
    PubMed     Abstract available

    February 2021
  271. THORNTON O, Daggett E, Zia L, Quian A, et al
    Counseling, Contraception, and Conception Rates in Patients Undergoing Bariatric Surgery: A Retrospective Review.
    Contraception. 2021 Feb 28. pii: S0010-7824(21)00053.
    PubMed     Abstract available

  272. STEINBERG JR, Marthey D, Xie L, Boudreaux M, et al
    Contraceptive method type and satisfaction, confidence in use, and switching intentions.
    Contraception. 2021 Feb 20. pii: S0010-7824(21)00051.
    PubMed     Abstract available

  273. LATACK KR, Yuen F, Wang C, Nguyen BT, et al
    Online community queries on hormonal male contraception: an analysis of the Reddit "Ask Me Anything" experience.
    Contraception. 2021 Feb 19. pii: S0010-7824(21)00050.
    PubMed     Abstract available

  274. CHAKRABORTY P, Gallo MF, Nawaz S, Smith M, et al
    Use of non-preferred contraceptive methods among women in Ohio.
    Contraception. 2021 Feb 16. pii: S0010-7824(21)00035.
    PubMed     Abstract available

  275. BERNDT VK, Bell AV
    Contextualizing Barriers to Long-Acting Reversible Contraception.
    Contraception. 2021 Feb 16. pii: S0010-7824(21)00036.
    PubMed     Abstract available

  276. BELL SO, Gemmill A
    Perceived likelihood of becoming pregnant and contraceptive use: Findings from population-based surveys in Cote d'Ivoire, Nigeria, and Rajasthan, India.
    Contraception. 2021 Feb 12. pii: S0010-7824(21)00031.
    PubMed     Abstract available

  277. MASTEY N, Matulich MC, Uhm S, Baker CC, et al
    U.S. referral center experience removing nonpalpable and difficult contraceptive implants with in-office ultrasonography: a case series.
    Contraception. 2021 Feb 8. pii: S0010-7824(21)00028.
    PubMed     Abstract available

  278. GIPSON JD, Bornstein M, Berger A, Rocca CH, et al
    Desire to Avoid Pregnancy and Contraceptive Use among Female Methadone Patients in Los Angeles.
    Contraception. 2021 Feb 7:9564. doi: 10.1016/j.contraception.2021.
    PubMed     Abstract available

  279. KIM C, Nguyen AT, Berry-Bibee E, Ermias Y, et al
    Systemic hormonal contraception initiation after abortion: a systematic review and meta-analysis.
    Contraception. 2021 Feb 3. pii: S0010-7824(21)00027.
    PubMed     Abstract available

  280. CANNON R, White K, Seifert B, Woodhams E, et al
    Exploring The Physician's Role in Contraceptive Counseling at the Time of Abortion in the US.
    Contraception. 2021 Feb 2. pii: S0010-7824(21)00024.
    PubMed     Abstract available

  281. GOLDMAN AR, Gerber SR
    Levonorgestrel intrauterine system (IUS) in a patient with uterine didelphys: A case report.
    Contraception. 2021;103:134-135.
    PubMed     Abstract available

    January 2021
  282. DUTTON C, Kim R, Janiak E
    Prevalence of contraindications to progestin-only contraceptive pills in a multi-institution patient database.
    Contraception. 2021 Jan 30. pii: S0010-7824(21)00020.
    PubMed     Abstract available

  283. CLELAND K, Marcantonio TL, Hunt ME, Jozkowski KN, et al
    "It prevents a fertilized egg from attaching...and causes a miscarriage of the baby": A qualitative assessment of how people understand the mechanism of action of emergency contraceptive pills.
    Contraception. 2021 Jan 25. pii: S0010-7824(21)00019.
    PubMed     Abstract available

  284. DEHLENDORF C, Fox E, Silverstein IA, Hoffman A, et al
    Development of the Patient-Centered Contraceptive Counseling scale (PCCC), a short form of the Interpersonal Quality of Family Planning Care scale.
    Contraception. 2021 Jan 25. pii: S0010-7824(21)00018.
    PubMed     Abstract available

  285. KRASHIN JW, Zapata LB, Morgan IA, Tepper NK, et al
    Required examinations and tests before initiating contraception: provider practices from a national cross-sectional survey.
    Contraception. 2021 Jan 14. pii: S0010-7824(21)00006.
    PubMed     Abstract available

  286. WILLIAMS BN, Jauk VC, Szychowski JM, Arbuckle JL, et al
    Adolescent Emergency Contraception Usage, Knowledge and Perception.
    Contraception. 2021 Jan 13. pii: S0010-7824(21)00005.
    PubMed     Abstract available

  287. KLIPPING C, Duijkers I, Mawet M, Maillard C, et al
    Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
    Contraception. 2021 Jan 8. pii: S0010-7824(21)00002.
    PubMed     Abstract available

  288. HYLTON-KONG T, Steiner MJ, Bailey A, Palazzi M, et al
    Debunking myths about contraceptive safety among women in Kingston, Jamaica: Pilot randomized controlled trial.
    Contraception. 2021 Jan 8. pii: S0010-7824(21)00003.
    PubMed     Abstract available

  289. EVANS ML, Qasba N, Shah Arora K
    COVID-19 highlights the policy barriers and complexities of postpartum sterilization.
    Contraception. 2021;103:3-5.
    PubMed     Abstract available

  290. CARR BR, Thomas MA, Gangestad A, Eisenberg DL, et al
    Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta(R)) discontinuation.
    Contraception. 2021;103:26-31.
    PubMed     Abstract available

  291. SEIDMAN D, Cavrois M, Hilton JF, Roan NR, et al
    Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: Results of an ex vivo fusion assay.
    Contraception. 2021;103:44-47.
    PubMed     Abstract available

    December 2020
  292. CHE Y, Li Y, Gu X, Jiang L, et al
    Contraception, unintended pregnancy, and induced abortion within 24 months of delivery in China: a retrospective cohort study.
    Contraception. 2020 Dec 27. pii: S0010-7824(20)30467.
    PubMed     Abstract available

  293. EGARDT A, Algovik M, Kallner HK
    Adherence to Swedish national recommendations for long acting reversible contraceptive provision at the time of medical abortion.
    Contraception. 2020 Dec 26. pii: S0010-7824(20)30466.
    PubMed     Abstract available

  294. ELLISON J, Cole MB, Hanchate AD, Kazis L, et al
    Non-Indicated Pelvic Examinations During Contraceptive Encounters: Prevalence and Provider Variations.
    Contraception. 2020 Dec 26. pii: S0010-7824(20)30464.
    PubMed     Abstract available

  295. BESHAR I, So J, Chelvakumar M, Cahill EP, et al
    Socioeconomic Differences Persist in Use of Permanent versus Long-Acting Reversible Contraception: An Analysis of the National Survey for Family Growth, 2006-2010 versus 2015-2017.
    Contraception. 2020 Dec 23. pii: S0010-7824(20)30461.
    PubMed     Abstract available

  296. NAMKUNG EH, Valentine A, Warner L, Mitra M, et al
    Contraceptive Use at First Sexual Intercourse among Adolescent and Young Adult Women with Disabilities: The Role of Formal Sex Education.
    Contraception. 2020 Dec 23. pii: S0010-7824(20)30460.
    PubMed     Abstract available

  297. SUNAGA T, Cicali B, Schmidt S, Brown J, et al
    Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system.
    Contraception. 2020 Dec 17. pii: S0010-7824(20)30439.
    PubMed     Abstract available

  298. HARRIS S, Kaneshiro B, Ahn HJ, Saito-Tom L, et al
    Timing of Insertion Affects Expulsion in Patients using the Levonorgestrel 52 mg Intrauterine System for Non-Contraceptive Indications.
    Contraception. 2020 Dec 5. pii: S0010-7824(20)30435.
    PubMed     Abstract available

  299. Corrigendum to "Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate" [Contraception 102(3) (2020) 168-173].
    Contraception. 2020;102:433.

  300. KATZ M, Newmark RL, Aronstam A, O'Grady N, et al
    An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA).
    Contraception. 2020;102:392-395.
    PubMed     Abstract available

    November 2020
  301. KIM CS, Lunde B, MacIsaac L, Arden M, et al
    Provision of Contraceptive Implants in School-Based Health Centers: A Cost-Effectiveness Analysis.
    Contraception. 2020 Nov 19. pii: S0010-7824(20)30420.
    PubMed     Abstract available

  302. STIFANI BM, Avila K, Levi EE
    Telemedicine for contraceptive counseling: an exploratory survey of US family planning providers following rapid adoption of services during the COVID-19 pandemic.
    Contraception. 2020 Nov 16. pii: S0010-7824(20)30416.
    PubMed     Abstract available

  303. SUMARSONO A, Segar MW, PharmD LX, Atem F, et al
    Medicaid Expansion and Provision of Prescription Contraception to Medicaid Beneficiaries.
    Contraception. 2020 Nov 16. pii: S0010-7824(20)30415.
    PubMed     Abstract available

  304. SHETH AN, Angert CD, Haddad LB, Mehta CC, et al
    Contraception methods used among women with HIV starting antiretroviral therapy in a large United States clinical trial, 2009-2011.
    Contraception. 2020 Nov 12. pii: S0010-7824(20)30414.
    PubMed     Abstract available

  305. CHARLTON BM, Reynolds CA, Janiak E, DiVasta AD, et al
    Sexual orientation-related differences in contraceptive use: a brief report based on a cohort of adolescent and young women.
    Contraception. 2020 Nov 12. pii: S0010-7824(20)30412.
    PubMed     Abstract available

  306. STRANSKY OM, Wolgemuth T, Kazmerski T, Chodoff A, et al
    Contraception Decision-Making and Care Among Reproductive-Aged Women with Autoimmune Diseases.
    Contraception. 2020 Nov 9. pii: S0010-7824(20)30406.
    PubMed     Abstract available

  307. HUYSMAN BC, Paul R, Rivera AN, Tal E, et al
    Patient and counselor satisfaction with structured contraceptive counseling by health center staff in federally qualified health centers.
    Contraception. 2020 Nov 5. pii: S0010-7824(20)30405.
    PubMed     Abstract available

    October 2020
  308. ECKHAUS LM, Ti AJ, Curtis KM, Stewart-Lynch AL, et al
    Patient and pharmacist perspectives on pharmacist-prescribed contraception: a systematic review.
    Contraception. 2020 Oct 29. pii: S0010-7824(20)30382.
    PubMed     Abstract available

  309. BUASAWAT P, Manonai J, Ngamjanyaporn P
    Perception of Contraceptive Counseling and Contraceptive Use among Systemic Lupus Erythematosus Patients.
    Contraception. 2020 Oct 29. pii: S0010-7824(20)30387.
    PubMed     Abstract available

  310. UHM S, Chen MJ, Cutler ED, Creinin MD, et al
    Twelve-month prescribing of contraceptive pill, patch, and ring before and after a standardized electronic medical record order change.
    Contraception. 2020 Oct 21. pii: S0010-7824(20)30381.
    PubMed     Abstract available

  311. HAVERINEN A, Kangasniemi M, Luiro K, Piltonen T, et al
    Ethinyl Estradiol vs Estradiol Valerate in Combined Oral Contraceptives - Effect on Glucose Tolerance: A Randomized, Controlled Clinical Trial.
    Contraception. 2020 Oct 21. pii: S0010-7824(20)30384.
    PubMed     Abstract available

  312. CHIRUVELLA M, Schaffir J, Benedict JA, Tedesco C, et al
    Is provision of contraception at discharge following delivery associated with postpartum visit attendance?
    Contraception. 2020 Oct 21. pii: S0010-7824(20)30385.
    PubMed     Abstract available

  313. EHN B, Anderberg P, Sanmartin Berglund J, Lilje S, et al
    The process of opting for female permanent contraception: A qualitative study of women's experiences in Sweden.
    Contraception. 2020 Oct 14. pii: S0010-7824(20)30359.
    PubMed     Abstract available

  314. ARCARA J, Arteaga S, Burny I, Manchikanti Gomez A, et al
    Changes in Expectation of Relationship Permanence, Pregnancy Acceptability and Desire, and Contraceptive Use Over Time Among Young Latino/a Women and Men: An Exploratory Analysis.
    Contraception. 2020 Oct 7. pii: S0010-7824(20)30356.
    PubMed     Abstract available

    September 2020
  315. PETERSON SF, Blumenthal PD
    Intra-abdominal placement of postplacental levonorgestrel intrauterine system: A case report.
    Contraception. 2020;102:224.

  316. CARUGNO J
    Post-placental intra-abdominal placement of levonorgestrel 52mg intrauterine system: A case report.
    Contraception. 2020;102:222-223.

    April 2020
  317. RODEN RC, Noritz G, McKnight ER, Bonny AE, et al
    An exploratory study of depot-medroxyprogesterone acetate and bone mineral density in adolescent and young adult women with cerebral palsy.
    Contraception. 2020;101:273-275.
    PubMed     Abstract available

  318. STULBERG DB, Datta A, White VanGompel E, Schueler K, et al
    One Key Question(R) and the Desire to Avoid Pregnancy Scale: A comparison of two approaches to asking about pregnancy preferences.
    Contraception. 2020;101:231-236.
    PubMed     Abstract available

  319. LAROCHE KJ, Wynn LL, Foster AM
    "We've got rights and yet we don't have access": Exploring patient experiences accessing medication abortion in Australia.
    Contraception. 2020;101:256-260.
    PubMed     Abstract available

  320. DENNIS A, Manski R, O'Donnell J
    Assessing research impact: A framework and an evaluation of the Society of Family Planning Research Fund's grantmaking (2007-2017).
    Contraception. 2020;101:213-219.
    PubMed     Abstract available

    March 2020
  321. LAPORTE M, Marangoni M Jr, Surita F, Juliato CT, et al
    Postplacental placement of intrauterine devices: A randomized clinical trial.
    Contraception. 2020;101:153-158.
    PubMed     Abstract available

  322. SRINIVASULU S, Shah SD, Schechter CB, Prine L, et al
    Effectiveness of clinical decision support to enhance delivery of family planning services in primary care settings.
    Contraception. 2020;101:199-204.
    PubMed     Abstract available

    February 2020
  323. MANZE MG, Calixte C, Romero DR, Roberts L, et al
    Physician perspectives on routine pregnancy intention screening and counseling in primary care.
    Contraception. 2020;101:91-96.
    PubMed     Abstract available

  324. RICHTER WH, Koytchev R, Kirkov V, Merki G, et al
    Comparative pharmacokinetic estimates of drospirenone alone and in combination with ethinyl estradiol after single and repeated oral administration in healthy females.
    Contraception. 2020;101:137-143.
    PubMed     Abstract available

    January 2020
  325. KAPP N, Methazia J, Eckersberger E, Griffin R, et al
    Label comprehension of a combined mifepristone and misoprostol product for medical abortion: A pilot study in South Africa.
    Contraception. 2020;101:46-52.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.